• SENSEX 72,781.89
    -251.89 (--0.34%)
  • BANKNIFTY 55,316.00
    -165.05 (--0.30%)
  • JSW Steel
    1,158.95 1,072.90(%)
  • NSE
    1,780.00 1,878.00(%)
  • SS Retail
    828.30 888.00(%)
  • Infosys
    1,095.90 1,727.85(%)
  • T R I L
    360.95 495.80(%)
  • Max Healthcare
    850.10 843.00(%)
  • IndusInd Bank
    866.00 725.90(%)
  • Cholaman.Inv.&Fn
    1,553.00 1,299.80(%)
  • Life Insurance
    391.35 361.00(%)
  • Reliance Industries
    1,187.90 1,611.20(%)
  • Tata Elxsi
    3,706.00 5,949.95(%)
  • Meesho
    226.45 125.70(%)
  • Elecon Engg.Co
    501.05 579.95(%)
  • HDFC Bank
    708.00 682.00(%)
  • TCS
    2,335.45 3,336.70(%)
  • MV Electrosystems
    999.00 999.00(%)
  • Voltas
    1,050.75 1,582.00(%)
  • Go Digit General
    284.75 373.40(%)
  • Hero Motors
    167.50 179.00(%)
  • B H E L
    463.60 463.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Parnax Lab Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 2018.0
  • ISIN : INE383L01019
110.72 -3 (-2.60%)
  • As on 14 Oct 2026 (EOD)

  • Today’s Low

    107.02

  • Today’s High

    113.80

  • Open

    113.80

  • Perv Close

    113.68

  • 52W Low

    104.00

  • 52W High

    149.50

Key Indicators

  • P/E(TTM)

    82.89

  • Mar.Cap (₹Cr.)

    127.17

  • Div & Yield %

    0.00

  • Book Value(₹)

    20.39

  • Debt-Equity Ratio

    -2.60

  • AGM Date

    14-Oct-2026

  • EPS

    1.33

  • P/E Ratio

    82.89

Financials Ratios

  • Debt-Equity Ratio

    1.01

  • Mar.Cap (₹Cr.)

    127.17

  • RONW (%)

    14.39

  • ROCE (%)

    12.87

Score Board

  • Equity (₹ in Cr.)

    11.49

  • BV (₹)

    20.40

  • Sales( ₹ in Cr.)

    6.63

  • NP (in Cr.)

    0.92

  • NP Var(%)

    -34.0

  • Div%

    0.0

  • CPS (₹)

    0.90

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    126.63

  • 52 Week High

    149.50

  • 52 Week Low

    104.00

  • Price BSE

    110.0

  • Price NSE

    111.00

  • Market Capital( in Cr.)

    126.63

  • P/C Ratio

    128.00

  • P/E Ratio

    137.00

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 6.63 7.02 7.44 7.47 7.15 2.37
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6.63 7.02 7.44 7.47 7.15 2.37
Other Income 2.37 0.71 0.54 0.37 0.16 0.07
Stock Adjustments -0.26 -0.13 0.25 0.00 0.00 0.00
Total Income 8.74 7.60 8.23 7.84 7.31 2.44
EXPENDITURE :            
Raw Materials 2.79 2.88 3.27 3.48 3.40 1.46
Power and Fuel Cost 0.02 0.02 0.02 0.02 0.11 0.14
Employee Cost 0.94 0.90 0.74 0.55 0.52 0.45
Other Manufacturing Expenses 1.01 1.05 1.01 1.12 1.08 0.30
Selling and Administration Expenses 0.49 0.79 0.55 0.59 0.47 0.35
Miscellaneous Expenses 2.74 0.00 0.01 0.15 0.20 0.12
Employee Benefit Expenses 0.94 0.90 0.74 0.55 0.52 0.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7.99 5.65 5.59 5.90 5.78 2.82
Operating Profit 0.74 1.94 2.65 1.94 1.53 -0.38
Interest 0.03 0.02 0.14 0.25 0.71 0.83
Gross Profit 0.71 1.92 2.51 1.69 0.82 -1.21
Depreciation 0.06 0.06 0.06 0.07 0.04 0.04
Profit Before Tax 0.65 1.86 2.45 1.62 0.78 -1.25
Current Tax 0.00 0.00 0.00 0.00 0.00 0.13
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.24 0.46 0.62 0.42 0.24 -0.25
Reported Net Profit 0.89 1.39 1.82 1.20 0.54 -1.13
Extraordinary Items -0.03 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.92 1.39 1.82 1.20 0.54 -1.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -5.27 -6.66 -8.49 -9.69 -10.23 -9.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -4.38 -5.27 -6.66 -8.49 -9.69 -10.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.77 1.21 1.59 1.05 0.55 -1.33
Earnings Per Share(Adj)-Unit Curr 0.77 1.21 1.59 1.05 0.55 -1.33
Book Value 20.39 19.63 18.42 16.85 11.14 5.54
Book Value(Adj)-Unit Curr 20.39 19.63 18.42 16.85 11.14 5.54

Shareholding Pattern

  • Promoter Group

    72.30%

  • Public Share Holding

    27.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,303,766 72.30 8,303,766 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,303,766 72.30 8,303,766 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 280,138 2.44 276,988 22
Clearing Members 4,201 0.04 4,201 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 106,303 0.93 106,303 70
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 153,928 1.34 153,928 96
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,229,535 10.71 1,229,535 26
Individuals holding nominal share capital up to Rs. 1 lakh 1,378,301 12.00 1,337,501 3,340
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 26,000 0.23 26,000 2
Sub Total 3,181,850 27.70 3,137,900 3,565
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,485,616 100.00 11,441,666 3,572

Company Background

Parnax Lab LtdPharmaceuticals - Indian - Formulations

  • Parnax Lab Ltd
  • BSE Code : 2018.0
  • ISIN : INE383L01019

  • Incorporation Year

    1982

  • Registered Office

    Gala 114 Bldg No 8
    Jogani Ind Complex Chunabhatti, Mumbai,
    Maharashtra-400022

  • Telephone

    91-022-6825 2525

  • FAX

    91-022-2405 7728

  • Chairman

  • Managing Director

  • Company Secretary

    Preet Kukreja

  • Auditor

    C N Patel & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Parnax Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Parnax Lab 110.25 8.99 6.63 84.81 2.44
Abbott India 26,346.00 7,217.19 6,929.05 34.67 43.78
Astrazeneca Phar 5,943.50 2,304.07 2,275.58 87.60 27.86
Glaxosmi. Pharma 2,539.40 3,932.76 3,790.20 40.57 58.17
Novartis India 1,988.85 393.10 354.33 50.22 15.94
Cipla 1,312.85 20,102.60 18,979.95 34.50 13.88
Bliss GVS Pharma 661.10 773.53 729.81 61.44 12.51
Amrutanjan Healt 503.10 520.13 502.55 26.95 24.16
Fermenta Biotec. 499.90 474.15 450.25 23.34 18.77
Guj. Themis Bio. 392.05 168.25 165.82 104.83 18.05
Ambalal Sarabhai 38.95 19.52 3.94 72.13 6.77